Partner

Two Manhattan West
375 Ninth Avenue
New York, NY 10001

+1-212-474-1438

Litigation Star

National Practice Area Star

Top 100 Trial Lawyers


Practice area:

Commercial
Competition/antitrust
Securities


Over the course of 34 years at Cravath, Daniel Slifkin has tried numerous cases in courts nationwide, as well as in domestic and international arbitrations. He is a fellow of the American College of Trial Lawyers.

“A real trial powerhouse” (Benchmark Litigation), Mr. Slifkin is among the few litigators to have taken a securities fraud class action through jury verdict, having tried two closely watched securities cases on behalf of Vivendi. In addition to securities and derivative matters, he has substantial experience in antitrust matters, bankruptcy proceedings and general commercial litigation. Mr. Slifkin also represents clients in regulatory investigations by the Department of Justice (DOJ), Securities and Exchange Commission (SEC) and European Union. In particular, he has considerable knowledge of the financial services industry, having represented numerous of the world’s leading financial institutions in a wide range of matters.

 

Updated Sep 2025

  • Mr. Slifkin represented Mr. Musk in winning a complete trial victory to defeat a $13 billion stockholder derivative action related to Tesla’s $2.1 billion acquisition of SolarCity Corporation. Following a highly publicized 11‑day trial, the court granted judgment in favor of Mr. Musk on all counts, and the judgment was affirmed by the Delaware Supreme Court.
  • Mr. Slifkin represented Robinhood in putative class action securities litigation—part of multidistrict litigation involving dozens of class actions centralized in Florida federal court—arising out of Robinhood’s decision to temporarily place certain limits on trading in certain securities in the face of unprecedented market volatility. The court denied class certification on the securities claims.

  • Mr. Slifkin is representing Sana Biotechnology, its CEO and CFO in putative class action securities litigation filed in Washington federal court alleging defendants made false and misleading statements concerning the company’s operations.

  • Competition/antitrust
  • Dispute resolution
  • Securities